Citation Impact
Citing Papers
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism
2009
Three-year outcomes after acute kidney injury: results of a prospective parallel group cohort study
2017
Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers
2016
Microbiota in health and diseases
2022 Standout
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
2021 Standout
Role of the normal gut microbiota
2015 Standout
Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins
2014
Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance
2011
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
2013 Standout
d-Galactose-induced accelerated aging model: an overview
2019 Standout
Oxidative stress, aging, and diseases
2018 Standout
Rheumatoid arthritis
2018 Standout
Protein-bound Uremic Toxins, Inflammation and Oxidative Stress: A Cross-sectional Study in Stage 3–4 Chronic Kidney Disease
2014
p -Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase
2013
Microbial tryptophan catabolites in health and disease
2018 Standout
The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease
2013
Prevalence and Control of Diabetes in Chinese Adults
2013 Standout
The role of autophagy in neurodegenerative disease
2013 Standout
Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients
2012
Inflammation in End-Stage Renal Disease-What Have We Learned in 10 Years?
2010
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure
2015
Albumin–drug interaction and its clinical implication
2013 Standout
Intestinal-Renal Syndrome: Mirage or Reality?
2011
Uremic Toxins and Their Effects on Multiple Organ Systems
2014
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Prospective Evaluation of the Change of Predialysis Protein‐Bound Uremic Solute Concentration With Postdilution Online Hemodiafiltration
2010
p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells
2012
Global epidemiology and outcomes of acute kidney injury
2018 Standout
Chronic kidney disease alters intestinal microbial flora
2012 Standout
Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease
2017
p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease
2010
Protein-Bound Molecules: A Large Family With a Bad Character
2014
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
2014 Standout
Intestinal microbiome and fitness in kidney disease
2019
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Cardiorenal Syndrome in Acute Kidney Injury
2018
Acute kidney injury
2021 Standout
Renal Clearance and Intestinal Generation of p-Cresyl Sulfate and Indoxyl Sulfate in CKD
2013
Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology
2015
Update on the Pharmacokinetics and Redox Properties of Protein-Bound Uremic Toxins
2011
Gut microbiota and inflammation in chronic kidney disease patients
2015
Uremic toxins originating from colonic microbial metabolism
2009
Microbiota issue in CKD: how promising are gut-targeted approaches?
2018
Uremic solutes from colon microbes
2012
Dysbiosis of the gut microbiota in disease
2015 Standout
Oxidative stress in chronic kidney disease
2018 Standout
Colonic Contribution to Uremic Solutes
2011
Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies
2017
Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy
2015
Effect of Magnesium Supplementation on Carotid Intima-Media Thickness and Flow-Mediated Dilatation among Hemodialysis Patients: A Double-Blind, Randomized, Placebo-Controlled Trial
2013
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Urinary p-cresol in autism spectrum disorder
2012
Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota
2016
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
2018 Standout
Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: A randomized clinical trial
2014
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)
2015
The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population
2011
p-Cresyl Sulfate Promotes Insulin Resistance Associated with CKD
2012
Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study
2010
A Bench to Bedside View of Uremic Toxins
2008
Chronic Kidney Disease
2016 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY)
2016
DNA methylation GrimAge strongly predicts lifespan and healthspan
2019 Standout
A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
2012 Standout
Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
2017
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Role of Altered Intestinal Microbiota in Systemic Inflammation and Cardiovascular Disease in Chronic Kidney Disease
2014
Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD)
2017
The Colon: An Overlooked Site for Therapeutics in Dialysis Patients
2013
Mitochondrial dysfunction in the pathophysiology of renal diseases
2013
Diabetic Kidney Disease
2017 Standout
The physical basis of renal fibrosis: effects of altered hydrodynamic forces on kidney homeostasis
2013
Arterial disease in chronic kidney disease
2012
Diet, the intestinal microbiota, and immune health in aging
2016
Precision Nutrition and the Microbiome, Part I: Current State of the Science
2019
Metabolism, Protein Binding, and Renal Clearance of Microbiota–Derived p-Cresol in Patients with CKD
2016
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
Microbial Contribution to the Human Metabolome: Implications for Health and Disease
2019
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression
2018
Is there Interaction Between Gut Microbial Profile and Cardiovascular Risk in Chronic Kidney Disease Patients?
2015
Biotic Supplements for Renal Patients: A Systematic Review and Meta-Analysis
2018
Works of Eva Schepers being referenced
Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications
2011
An update on uremic toxins
2012
Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration
2012
The Gut: The Forgotten Organ in Uremia?
2010
Inconsistency of Reported Uremic Toxin Concentrations
2007
Flow cytometric calcium flux assay: Evaluation of cytoplasmic calcium kinetics in whole blood leukocytes
2009
Chronic kidney disease progression is mainly associated with non-recovery of acute kidney injury
2015
The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate
2014
Protein-Bound Uremic Toxins Stimulate Crosstalk between Leukocytes and Vessel Wall
2013
P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production
2006
Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes
2008
Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?
2013
Symmetric Dimethylarginine as a Proinflammatory Agent in Chronic Kidney Disease
2011
Guanidino Compounds as Cause of Cardiovascular Damage in Chronic Kidney Disease: An in vitro Evaluation
2010
An Update on Protein-Bound Uremic Retention Solutes
2011
Estimated Glomerular Filtration Rate Is a Poor Predictor of Concentration for a Broad Range of Uremic Toxins
2011
Progress in Uremic Toxin Research: Genetics/Genomics in Chronic Kidney Disease—Towards Personalized Medicine?
2009
Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease
2009
Uremic Toxins in Chronic Renal Failure
2007
Review on uraemic solutes II Variability in reported concentrations: causes and consequences
2007
Evolution of protein-bound uraemic solutes during predilution haemofiltration.
2009